In the BioHarmony Drug Report Database

"Preview" Icon

Docosanol

Abreva (docosanol) is a small molecule pharmaceutical. Docosanol was first approved as Abreva on 2000-07-25. It is used to treat blister in the USA.

 

Trade Name

 

Abreva
 

Common Name

 

docosanol
 

ChEMBL ID

 

CHEMBL1200453
 

Indication

 

blister
 

Drug Class

 

Image (chem structure or protein)

Docosanol structure rendering